Building better iPSC models
Our activities strengthen regenerative medicine by building better iPSC models. These broaden our knowledge of the biology of iPSCs and their differentiated progeny, to screen for modulators of their biological behavior, and to build personalized models of disease that aid physicians in developing new therapeutic approaches.
Together with the Netherlands Cancer Institute and Leiden University, we serve as a national infrastructure (ScreeninC) to support targeted and genome-wide CRISPR functional screens.
Visit the Netherlands Cancer Institute
Visit Leiden University
Visit national infrastructure ScreeninC